Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden

Journal of Medical Screening

Volumn 16, Issue 1, 2009, Pages 39-45

  Bordás, Pál ^a,b   Jonsson, Håkan ^b   Nyström, Lennarth ^b   Lenner, Per ^b  

^a SUNDERBY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; CONFIDENCE INTERVAL; EPISODE SENSITIVITY; FEMALE; HUMAN; INTERVAL CANCER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRACTICE GUIDELINE; PREVALENCE; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STATISTICAL PARAMETERS; SWEDEN; BREAST TUMOR; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SWEDEN;

EID: 67049165497     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2009.008098     Document Type: Article

References (21)

1. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th edn. Luxembourg: European Commission, 2006
2. Bjurstam N, Björnelid L, Duffy SW, et al. The Gothenburg breast screening trial. First results on mortality, incidence and mode of detection for women 39-49 years at randomization. Cancer 1997;80:2091-2099
3. Frisell J, Eklund G, Hellström L, Somell A. Analysis of interval carcinoms in a randomised screening trial in Stockholm. Breast Cancer Res Treat 1987;9:219-225 (Pubitemid 17135147)
4. Tabár L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Rad Clin N Am 1992;30:187-210
5. Vitak B. Invasive interval cancers in the Ostergotland Mammographic Screening Programme: radiological analysis. Eur Radiol 1998;8: 639-646 (Pubitemid 128546289)
6. Zackrisson S, Janzon L, Manjer J, Andersson I. Improved survival rate for women with interval breast cancer-results from the breast cancer screening programme in Malmö, Sweden. J Med Screen 2007;14:138-143 (Pubitemid 47511123)
7. Day N, McCann J, Camilleri-Ferrante C, et al. Monitoring interval cancers in breast screening programmes: the East Anglian experience. J Med Screen 1995;2:180-185
8. Fracheboud J, de Koning HJ, Beemsterboer PMM, et al. Interval cancers in the Dutch breast screening programme. Br J Cancer 1999;81:912-917 (Pubitemid 29504707)
9. Kavanagh AM, Mitchell H, Farrugia H, Giles GG. Monitoring interval cancers in an Australian mammographic screening programme. J Med Screening 1999;6:139-143 (Pubitemid 29526261)
10. Peeters PHM, Verbeek ALM J, Hendricks JHLC, Holland R, Mravunac M, Vooijs GP. The occurrance of interval cancers in the Nijmegen screening programme. Br J Cancer 1989;59:929-932 (Pubitemid 19155710)
11. Wang H, Bjurstam N, Bjørndal H, et al. Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. Int J Cancer 2001;94:594-598 (Pubitemid 32982142)
12. Zappa M, Falini P, Bonardi R, et al. Monitoring interval cancers in mammographic screening: the Florence Distric programme experience. Breast 2002;11:301-305 (Pubitemid 35174946)
13. Houssami N, Irwig L, Ciatto S. Radiological surveillance of interval breast cancers in screening programmes. Lancet Oncol 2006;7:259-265 (Pubitemid 43286455)
14. Hakama M, Auvinen A, Day NE, Miller AB. Sensitivity in cancer screening. J Med Screen 2007;14:174-177 (Pubitemid 350223780)
15. Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A. Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int J Cancer 2006;118:174-179 (Pubitemid 41681595)
16. Taylor R, Page A, Bampton D, Estoesta J, Rickard M. Age-specific interval breast cancers in New SouthWales and meta-analysis of studies of women aged 40-49 years. J Med Screen 2004;11:199-206 (Pubitemid 40006744)
17. Bordás P, Jonsson H, Nyström L, Lenner P. Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden. Breast 2007;16:47-54 (Pubitemid 46172856)
18. Bulliard JL, Sasieni P, Klabunde C, De Landtsheer JP, Yankaskas BC, Fracheboud J. Methodological issues in international comparison of interval breast cancers. Int J Cancer 2006;119:1158-1163 (Pubitemid 44116926)
19. Taylor R, Supramaniam R, Rickard M, Estoesta J, Moreira C. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes. J Med Screen 2002;9:20-25 (Pubitemid 34327138)
20. Hofvind S, Bjurstam N, Sørum R, Bjørndal H, Thoresen S, Skaane P. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme. J Med Screen 2006;13:192-196 (Pubitemid 46057727)
21. Rutqvist LE. Validity of certified causes of death in breast carcinoma patients. Acta Radiologica-Oncology 1985;24:385-390 (Pubitemid 16177237)